Stockscreener 앱 받기
3.20%
시간 외 거래:
전일 마감가:
$89.65
열려 있는:
$90.52
하루 거래량:
5.45M
Relative Volume:
1.28
시가총액:
$44.98B
수익:
$6.13B
순이익/손실:
$272.21M
주가수익비율:
167.58
EPS:
0.5521
순현금흐름:
$1.38B
1주 성능:
+5.82%
1개월 성능:
+15.46%
6개월 성능:
+19.64%
1년 성능:
+47.02%
1일 변동 폭
$89.71
$92.86
1주일 범위
$87.64
$92.86
52주 변동 폭
$62.06
$92.86
벤타스 Stock (VTR) Company Profile
명칭
Ventas Inc
전화
(312) 660-3800
주소
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
92.52 | 43.17B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
236.06 | 160.22B | 11.75B | 1.46B | 2.19B | -0.6014 |
DOC
Healthpeak Properties Inc
|
21.89 | 14.75B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
49.40 | 14.20B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
55.04 | 10.78B | 2.37B | 101.67M | 169.19M | 0.5775 |
벤타스 Stock (VTR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 개시 | Goldman | Buy |
| 2025-10-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-09-19 | 개시 | UBS | Neutral |
| 2025-06-23 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-03-07 | 업그레이드 | Argus | Hold → Buy |
| 2025-01-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-02-26 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | 개시 | Deutsche Bank | Buy |
| 2024-01-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-11-07 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2023-10-11 | 개시 | Exane BNP Paribas | Outperform |
| 2023-10-03 | 개시 | Wedbush | Neutral |
| 2023-09-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-06-23 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | 개시 | Wells Fargo | Overweight |
| 2022-11-01 | 재확인 | Credit Suisse | Outperform |
| 2022-11-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-06-23 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | CapitalOne | Overweight |
| 2022-05-18 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-02-01 | 개시 | Credit Suisse | Neutral |
| 2022-01-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2021-12-14 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-11-22 | 다운그레이드 | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-09-23 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2021-08-26 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | 재개 | Mizuho | Neutral |
| 2021-06-15 | 개시 | Wolfe Research | Outperform |
| 2021-06-11 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-05-13 | 업그레이드 | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | 다운그레이드 | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | 개시 | Robert W. Baird | Neutral |
| 2020-11-30 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2020-11-10 | 업그레이드 | Jefferies | Underperform → Hold |
| 2020-09-08 | 다운그레이드 | Argus | Buy → Hold |
| 2020-09-02 | 재개 | Stifel | Hold |
| 2020-08-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2020-08-14 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-03-25 | 업그레이드 | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | 다운그레이드 | Jefferies | Buy → Underperform |
| 2020-02-28 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-12-20 | 재개 | Mizuho | Neutral |
| 2019-12-10 | 다운그레이드 | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | 업그레이드 | Argus | Hold → Buy |
| 2019-10-30 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-10-28 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | 다운그레이드 | Citigroup | Buy → Neutral |
모두보기
벤타스 주식(VTR)의 최신 뉴스
Ventas Inc. focuses on senior housing and healthcare real estate - AD HOC NEWS
Evercore ISI Adjusts Ventas Price Target to $96 From $95, Maintains Outperform Rating - marketscreener.com
Louisiana State Employees Retirement System Invests $1.98 Million in Ventas, Inc. $VTR - MarketBeat
Is Ventas stock outperforming the Dow? - MSN
Ventas announces Q2 2026 earnings release date - scanx.trade
Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call - Business Wire
Technical Reactions to VTR Trends in Macro Strategies - Stock Traders Daily
Are You Looking for a High-Growth Dividend Stock? - Yahoo Finance
Ventas Inc To Go Ex-Dividend On June 30th, 2026 With 0.52 USD Dividend Per Share - Moomoo
Ventas adjusts senior leadership, REIT stock in sector focus - AD HOC NEWS
Ventas names head of outpatient medical research property unit - Crain's Chicago Business
Patton Fund Management Inc. Sells 60,624 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas clears S&P 500 healthcare benchmark, shares reflect steady REIT profile - AD HOC NEWS
Chicago REIT Pays $32M for Little Rock Site (Real Deals) - Arkansas Business
The senior housing portfolio from Ventas Inc.stable rents and healthcare demand - AD HOC NEWS
Price to earnings forward of Ventas, Inc. – BOATS:VTR - TradingView
Ventas, Inc.(NYSE: VTR) added to Russell 1000 Defensive Index - marketscreener.com
Is Ventas (VTR) Rewriting Its Risk Profile With New Outpatient Leadership And Interim Legal Steward? - Sahm
Ventas opens the week with a strategy focus, shares in the US healthcare REIT sector - Ad-hoc-news.de
Union Bancaire Privee UBP SA Acquires 33,030 Shares of Ventas, Inc. $VTR - MarketBeat
Sterling Capital Management LLC Cuts Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas opens the weekend with a clear strategy focus, shares on the NYSE radar - Ad-hoc-news.de
46,134 Shares in Ventas, Inc. $VTR Purchased by OP Asset Management Ltd - MarketBeat
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventyx Biosciences clarifies pipeline strategy, shares react to sector volatility - Ad-hoc-news.de
Ventas Inc. highlights senior housing growth, REIT shares in S&P 500 focus - Ad-hoc-news.de
Ventas updates its senior notes filing, REIT stock under investor scrutiny - Ad-hoc-news.de
Ventas (VTR) Citi’s Miami Global Property CEO Conference 2026 Summary - Quartr
Ventas, Inc. Actuals & Estimates (NYSE:VTR) - TradingView
Ventas, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh Actuals & Estimates (BMFBOVESPA:V1TA34) - TradingView
Price to sales forward of Ventas, Inc. – NYSE:VTR - TradingView
Enterprise value to EBIT forward of Ventas, Inc. – NYSE:VTR - TradingView
Enterprise value to revenue forward of Ventas, Inc. – NYSE:VTR - TradingView
Ventas, Inc. Actuals & Estimates (BX:VEN) - TradingView
Is Holding Ventas Stock Still a Smart Move for Your Portfolio Now? - TradingView
Ventas Inc. updates leadership in outpatient medical properties, shares in S&P 500 healthcare real e - Ad-hoc-news.de
VTR Forecast — Price Target — Prediction for 2027 - TradingView
Friedenthal Financial Acquires Shares of 11,847 Ventas, Inc. $VTR - MarketBeat
SG Americas Securities LLC Has $25.48 Million Position in Ventas, Inc. $VTR - MarketBeat
Ventas Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Ventas announces leadership change in outpatient platform, shares in S&P 500 healthcare REIT focus - Ad-hoc-news.de
Ventas Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
The Senior Living Communities from Ventas Inc.healthcare real estate that runs quietly in the bac - Ad-hoc-news.de
Ventas Appoints Andrew L. Wattula as Executive Vice President of Outpatient Medical and Research - geneonline.com
Ventas, Inc. Announces Appointment of Andrew L. Wattula as Executive Vice President, Outpatient Medical & Research, Effective August 2026 - marketscreener.com
Diversified Trust Co Purchases 32,436 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas StockAnalyst consensus and dividend profile in focus - AD HOC NEWS
Ventas taps Hudson Pacific COO to run medical research properties - Stock Titan
World Investment Advisors Invests $1.91 Million in Ventas, Inc. $VTR - MarketBeat
Hsbc Holdings PLC Grows Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Groupama Asset Managment Lowers Holdings in Ventas, Inc. $VTR - MarketBeat
벤타스 (VTR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.16%
자본화:
|
볼륨(24시간):